Loading...

Relay Therapeutics, Inc.

RLAY•NASDAQ
Healthcare
Biotechnology
$12.71
$-2.24(-15.02%)
U.S. Market is Open • 11:05

Relay Therapeutics, Inc. (RLAY) Stock Overview

Explore Relay Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.3B
P/E Ratio-8.11
EPS (TTM)$-1.61
ROE-0.43%
Fundamental Analysis

AI Price Forecasts

1 Month$9.94
3 Months$13.29
1 Year Target$8.26

RLAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Relay Therapeutics, Inc. (RLAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.54, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $8.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.11 and a market capitalization of 2.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-12.84%
5-Day Change
-20.35%
1-Month Change
35.73%
3-Month Change
70.33%
6-Month Change
73.27%
Year-to-Date (YTD) Change
54.02%
1-Year Change
299.69%
3-Year Change
14.60%
5-Year Change
-61.22%
All-Time (Max) Change
-62.82%

Contact Information

https://www.relaytx.com
617 370 8837
399 Binney Street, Cambridge, MA, 02139

Company Facts

259 Employees
IPO DateJul 16, 2020
CountryUS
Actively Trading

Frequently Asked Questions